4//SEC Filing
Sheehy Douglas T. 4
Accession 0000899243-20-001533
CIK 0001631650other
Filed
Jan 20, 7:00 PM ET
Accepted
Jan 21, 6:17 PM ET
Size
10.0 KB
Accession
0000899243-20-001533
Insider Transaction Report
Form 4
Sheehy Douglas T.
See Remarks
Transactions
- Exercise/Conversion
Common Stock, $0.0001 par value
2020-01-16$12.95/sh+400$5,180→ 46,068 total - Sale
Common Stock, $0.0001 par value
2020-01-16$37.00/sh−400$14,800→ 45,668 total - Exercise/Conversion
Stock Option (right to buy)
2020-01-16−400→ 53,249 totalExercise: $12.95Exp: 2026-04-29→ Common Stock (400 underlying)
Footnotes (4)
- [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by Reporting Person.
- [F2]Includes 29,617 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F3]Includes 12,500 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F4]The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on April 4, 2017 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to Reporting Person's continued service relationship with Issuer on each such vesting date.
Documents
Issuer
Aimmune Therapeutics, Inc.
CIK 0001631650
Entity typeother
Related Parties
1- filerCIK 0001488637
Filing Metadata
- Form type
- 4
- Filed
- Jan 20, 7:00 PM ET
- Accepted
- Jan 21, 6:17 PM ET
- Size
- 10.0 KB